|
KIAA1107 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.171700000415E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.201920E-04 |
| Normal-vs-Stage2 |
1.83565999999358E-05 |
| Normal-vs-Stage3 |
8.79029999900638E-08 |
| Normal-vs-Stage4 |
3.51390000000729E-05 |
| Stage1-vs-Stage2 |
7.061600E-02 |
| Stage1-vs-Stage3 |
1.849530E-02 |
| Stage1-vs-Stage4 |
1.171040E-01 |
| Stage2-vs-Stage3 |
9.215200E-01 |
| Stage2-vs-Stage4 |
8.051800E-01 |
| Stage3-vs-Stage4 |
8.484000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.47390000004854E-06 |
| Normal-vs-AfricanAmerican |
1.798390E-02 |
| Normal-vs-Asian |
3.752400E-04 |
| Caucasian-vs-AfricanAmerican |
6.937000E-01 |
| Caucasian-vs-Asian |
8.285800E-01 |
| AfricanAmerican-vs-Asian |
6.234800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.400220E-04 |
| Normal-vs-Female |
2.13880000043964E-07 |
| Male-vs-Female |
3.691400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.338700E-03 |
| Normal-vs-Age(41-60Yrs) |
6.4597000004607E-07 |
| Normal-vs-Age(61-80Yrs) |
6.44869999955056E-07 |
| Normal-vs-Age(81-100Yrs) |
1.04900000019725E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.830400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.260400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.018500E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.581600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.564200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.082280E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.118500E-03 |
| Classical-VS-Follicular |
6.844500E-02 |
| Classical-VS-Other |
3.942400E-01 |
| Classical-VS-Normal |
3.56820000000369E-05 |
| Tall-VS-Follicular |
3.685800E-01 |
| Tall-VS-Other |
2.153800E-01 |
| Tall-VS-Normal |
1.54060000001621E-06 |
| Follicular-VS-Other |
1.958150E-01 |
| Follicular-VS-Normal |
1.69217000000055E-05 |
| Other-VS-Normal |
4.649200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.63829999461274E-08 |
| Normal-vs-N1 |
4.629500E-04 |
| N0-vs-N1 |
4.988000E-01 |
|
|
